我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

无保护左主干病变患者32例经皮冠状动脉介入治疗临床观察

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2015年第2期
页码:
161-164
栏目:
临床研究
出版日期:
2014-10-25

文章信息/Info

Title:
Clinical observation of percutaneous coronary intervention in 32 patients with unprotected left main coronary artery disease
作者:
肖建强; 何国平; 李 勇; 高 磊; 施有为; 杨海涛; 周惠芬
(常州市武进人民医院心血管内科，江苏 常州 213002)
Author(s):
XIAO Jian-qiang;  HE Guo-ping;  LI Yong;  GAO Lei;  SHI You-wei;  YANG Hai-tao;  ZHOU Hui-fen
(Department of Cardiology, Wujin People’s Hospital, Changzhou 213002, Jiangsu, China)
关键词:
无保护左主干; 经皮冠状动脉介入治疗
Keywords:
unprotected left main coronary artery;  percutaneous coronary intervention
分类号:
R541.4
DOI:
-
文献标识码:
A
摘要:
目的:评估无保护左主干冠状动脉（UPLMCA）病变患者行经皮冠脉介入治疗（PCI）的安全性和有效性。方法:回顾分析2009年9月~2013年8月完成的32例行PCI治疗的UPLMCA病变患者的临床资料。结果:32例UPLMCA病变患者中非分叉病变11例，分叉病变21例；所有患者均接受了支架植入术，其中单支架23例，单支架+球囊对吻5例，双支架4例；术中发生迷走反射和边支闭塞致小面积心肌梗死各1例，另1例（SYNTAX评分为37分）于PCI术后4 d死于支架内亚急性血栓形成；出院后随访5~51（22±13）个月，随访率100%，随访期间死亡1例（3%）、发现再狭窄后行靶血管重建3例（9%）；住院期间及随访期间总主要心脑血管不良事件发生率19%（6/32）。 结论:经选择的UPLMCA病变患者行PCI安全可行，近、中期疗效良好。
Abstract:
AIM:To evaluate the safety and efficacy of percutaneous coronary intervention (PCI) for unprotected left main coronary artery (UPLMCA) disease. METHODS: Clinical data of 32 patients with UPLMCA disease who received PCI from September 2009 to August 2013 were analyzed retrospectively. RESULTS: Of the 32 cases, there were 11 cases of non-bifurcation lesion and 21 cases of bifurcation lesion. Stent implantations were performed in all patients, including 23 cases of single stent, five cases of single stent plus kissing balloon and four cases of double stents. Intraoperative vagal reflex occurred in one case and side branch occlusion-induced small area myocardial infarction occurred in one case. One patient (SYNTAX score 37) died from subacute stent thrombosis 4 days after PCI. All patients were followed up for 21.53±12.89 months. Death occurred in one case (3.13%) and target vascular remodeling because of stent restenosis in three cases (9.38%) during the follow-up period. The total occurrence of major adverse cardiac and cerebrovascular events during hospitalization and follow-up periods was 18.75% (6/32). CONCLUSION: PCI for selected patients with UPLMCA disease is safe and feasible and produces good short- and medium-term efficacy.

参考文献/References

[1]李俭强,李为民,薛竟宜,等.无保护左主干病变介入治疗并发症防治进展[J].中国介入心脏病学杂志,2013,21(1):53-55.
[2]杨菲菲,王 禹.药物支架时代无保护左主干病变介入治疗的新策略[J].中国循环杂志,2009,24(3):236-238.
[3]Taggart DP,Kaul S,Boden WE,et al.Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery[J].J Am Coll Cardiol,2008,51(9):885-892.
[4]Mark DB,Nelson CL,Califf RM,et al.Continuing evolution of therapy for coronary artery disease.initial results from the era of coronary angioplasty[J].Circulation,1994,89(5):2015-2025.
[5]Sianos G,Morel MA,Kappetein AP,et al.The SYNTAX score:an agiographic tool grading the complexity of coronary artery disease[J].EuroIntervention,2005,1(2):219-227.
[6]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.经皮冠状动脉介入治疗指南(2009)[J].中华心血管病杂志,2009,37(1):4-25.
[7]Serruys PW,Morice MC,Kappetein AP,et al.Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease[J].N Engl J Med,2009,360(10):961-972.
[8]Kappetein AP,Feldman TE,Mack MJ,et al.Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease:3-year follow-up of the SYNTAX trial[J].Eur Heart J,2011,32(17):2125-2134.
[9]Chieffo A,Magni V,Latib A,et al.5-Year outcomes following percutaneous coronary intervention with Drug-Eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions(the Milan experience)[J].JACC Cardiovasc Interv,2010,3(6):595-601.
[10]Chieffo A,Morici N,Maisano F,et al.Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis - A single-center experience[J].Circulation,2006,113(21):2542-2547.
[11]Seung KB,Park DW,Kim YH,et al.Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease[J].N Engl J Med,2008,358(17):1781-1792.
[12]Park DW,Seung KB,Kim YH,et al.Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease:5-year results from the MAIN-COMPARE(Revascularization for Unprotected Left Main Coronary Artery Stenosis:Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization)registry[J].J Am Coll Cardiol,2010,56(2):117-124.
[13]Wijns W,Kolh P,Danchin N,et al.Guidelines on myocardial revascularization[J].Eur Heart J,2010, 31(20):2501-2555.
[14]Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American college of cardiology foundation/American heart association task force on practice guidelines and the society for cardiovascular angiography and interventions[J].Circulation,2011,124(23):e574-e651.
[15]Sheiban I,Sillano D,Biondi-Zoccai G,et al.Incidence and management of restenosis after treatment of unprotected left main disease with Drug-Eluting stents:70 restenotic cases from a cohort of 718 patients:FAILS(failure in left main study)[J].J Am Coll cardiol,2009, 54(13):1131-1136.

备注/Memo

备注/Memo:
收稿日期：2014-06-18.
通讯作者：何国平，教授，主要从事冠心病介入研究 Email：guopinghe6@sina.com
作者简介：肖建强，副主任医师 Email:jqx1977@sina.com
更新日期/Last Update: 2014-11-18